Recurrent Low-grade endometrial stromal sarcoma metastasized to the common iliac veins, extending into the inferior vena cava and right atrium after 12 years: A case report

IF 1.2 Q3 OBSTETRICS & GYNECOLOGY

Gynecologic Oncology Reports Pub Date : 2024-11-06 DOI:10.1016/j.gore.2024.101543

Nour Naaman , Mohammad Alyafi , Heitham Albeshri , Ahmed A Jamjoom , Samira AlTurkistany , Haneen Al-Maghrabi , Saeed Baradwan

{"title":"Recurrent Low-grade endometrial stromal sarcoma metastasized to the common iliac veins, extending into the inferior vena cava and right atrium after 12 years: A case report","authors":"Nour Naaman , Mohammad Alyafi , Heitham Albeshri , Ahmed A Jamjoom , Samira AlTurkistany , Haneen Al-Maghrabi , Saeed Baradwan","doi":"10.1016/j.gore.2024.101543","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Extrauterine recurrent metastasis of Low-grade endometrial stromal sarcoma (LG-ESS) to major blood vessels is largely rare with few reported cases.</div></div><div><h3>Case</h3><div>Herein, we present a case of a 51-year-old female with recurrent LG-ESS that has metastasized after 12 years to the inferior vena cava (IVC) and extended into the right atrium and common iliac veins. Computed tomography showed an intracardiac larger thrombus within the right atrium extending into the inferior vena cava and common iliac veins. The patient underwent cytoreduction of the intravenous tumor. Final histopathology confirmed metastatic LG-ESS. Follow-up CT scan after six months showed no residual or recurrence.</div></div><div><h3>Conclusion</h3><div>Treatment for extrauterine metastasis from LG-ESS prioritizes reducing tumor burden through surgical resection and may require collaboration across disciplines. Follow-up hormonal therapy with progestins or aromatase inhibitors significantly impacts patient prognosis.</div></div>","PeriodicalId":12873,"journal":{"name":"Gynecologic Oncology Reports","volume":"56 ","pages":"Article 101543"},"PeriodicalIF":1.2000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic Oncology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352578924002224","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

Extrauterine recurrent metastasis of Low-grade endometrial stromal sarcoma (LG-ESS) to major blood vessels is largely rare with few reported cases.

Case

Herein, we present a case of a 51-year-old female with recurrent LG-ESS that has metastasized after 12 years to the inferior vena cava (IVC) and extended into the right atrium and common iliac veins. Computed tomography showed an intracardiac larger thrombus within the right atrium extending into the inferior vena cava and common iliac veins. The patient underwent cytoreduction of the intravenous tumor. Final histopathology confirmed metastatic LG-ESS. Follow-up CT scan after six months showed no residual or recurrence.

Conclusion

Treatment for extrauterine metastasis from LG-ESS prioritizes reducing tumor burden through surgical resection and may require collaboration across disciplines. Follow-up hormonal therapy with progestins or aromatase inhibitors significantly impacts patient prognosis.

查看原文本刊更多论文

复发性低级别子宫内膜间质肉瘤12年后转移至髂总静脉，并延伸至下腔静脉和右心房：病例报告

导言宫外低级别子宫内膜间质肉瘤（LG-ESS）复发转移至大血管的病例非常罕见，鲜有报道。本病例为一例51岁女性，LG-ESS复发12年后转移至下腔静脉（IVC），并延伸至右心房和髂总静脉。计算机断层扫描显示，右心房内的心内大血栓延伸至下腔静脉和髂总静脉。患者接受了静脉内肿瘤细胞减灭术。最终的组织病理学证实了转移性 LG-ESS。结论LG-ESS宫外转移的治疗优先考虑通过手术切除减轻肿瘤负担，可能需要跨学科合作。使用孕激素或芳香化酶抑制剂进行后续激素治疗对患者的预后有显著影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gynecologic Oncology Reports OBSTETRICS & GYNECOLOGY-

CiteScore

2.00

自引率

0.00%

发文量

183

审稿时长

41 days

期刊介绍： Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.